What is Global Plasminogen Market?
The Global Plasminogen Market is a vast and dynamic sector that deals with the production, distribution, and consumption of plasminogen, a vital protein involved in the breakdown of blood clots. This market is a significant part of the global healthcare and pharmaceutical industry, playing a crucial role in the treatment of various health conditions. The market's value was estimated at US$ 13820 million in 2022, and it is projected to grow to US$ 19260 million by 2029, expanding at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2029.
Intravenous Injection, Eye Drops in the Global Plasminogen Market:
The Global Plasminogen Market is segmented based on the method of administration, with intravenous injection and eye drops being the primary categories. Intravenous injection is a common method of delivering plasminogen, especially in severe cases where immediate action is required. On the other hand, eye drops are used for conditions affecting the eye, such as ligneous conjunctivitis. This segment holds the largest share in the market, accounting for about 88% of the total.
Ligneous Conjunctivitis, Diabetic Foot, Wound Healing, Others in the Global Plasminogen Market:
The Global Plasminogen Market finds its applications in various areas, including the treatment of ligneous conjunctivitis, diabetic foot, wound healing, and others. Ligneous conjunctivitis is a rare form of chronic conjunctivitis characterized by the development of fibrin-rich, woody-like pseudomembranous lesions on the tarsal conjunctiva. Plasminogen eye drops have been found to be effective in treating this condition. In the case of diabetic foot, a condition common among people with diabetes, plasminogen is used to promote wound healing and prevent the development of ulcers.
Global Plasminogen Market Outlook:
The Global Plasminogen Market is geographically diverse, with North America being the largest market, accounting for about 45% of the total market share. This can be attributed to the advanced healthcare infrastructure, high awareness levels, and the presence of key market players in the region. Europe follows North America, holding about 20% of the market share. The presence of a well-established healthcare system and high expenditure on healthcare are some of the factors contributing to the growth of the plasminogen market in Europe.
| Report Metric | Details |
| Report Name | Plasminogen Market |
| Accounted market size in 2022 | US$ 13820 in million |
| Forecasted market size in 2029 | US$ 19260 million |
| CAGR | 4.8% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Kedrion, Prometic, Genentech (Roche), Boehringer Ingelheim, Kyowa Hakko Kirin, Omeros Corporation |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
